The clinical features of Angelman syndrome (AS) comprise severe mental retardation, postnatal microcephaly, macrostomia and prognathia, absence of speech, ataxia, and a happy disposition. We report on seven patients who lack most of these features, but presented with obesity, muscular hypotonia and mild mental retardation. Based on the latter findings, the patients were initially suspected of having Prader-Willi syndrome. DNA methylation analysis of SNRPN and D15S63, however, revealed an AS pattern, ie the maternal band was faint or absent. Cytogenetic studies and microsatellite analysis demonstrated apparently normal chromosomes 15 of biparental inheritance. We conclude that these patients have an imprinting defect and a previously unrecognised form of AS. The mild phenotype may be explained by an incomplete imprinting defect or by cellular mosaicism.
Introduction
Angelman syndrome (AS) and Prader-Willi syndrome (PWS) are distinct genetic disorders caused by a deficiency of imprinted gene expression from the maternal or paternal chromosome 15. AS is characterised by microcephaly, severe mental retardation, lack of speech, macrostomia and prognathia, ataxia, seizures, and a happy disposition. [1] [2] [3] In infants and adults the clinical diagnosis is often difficult and therefore the frequency of AS is probably underestimated. PWS is characterised by muscular hypotonia and feeding problems in newborns, obesity, short stature, hypogonadism and behavioural problems. Mental retardation in PWS is usually much milder than in AS. PWS is often wrongly suspected in patients with obesity and mental retardation, which occur in many different disorders. Today, the clinical diagnosis of PWS can easily be confirmed by molecular tests. 4 In contrast, 20% of AS patients have no detectable molecular defect.
Several molecular defects leading to the loss of function of the AS gene(s) and PWS gene(s) have been recognised. 5 Approximately 70% of patients with AS and PWS have a de novo maternally or paternally derived deletion in the chromosomal region 15q11-q13. Most of the other patients with PWS have two chromosomes 15 of maternal origin (uniparental maternal disomy), whereas uniparental paternal disomy occurs in only 1-2% of patients with AS. Mutations of the UBE3A gene, which is imprinted in brain cells, are found in 2-4% of AS patients. A small number of patients with PWS and AS have apparently normal chromosomes of biparental origin, but the paternal chromosome 15 carries a maternal imprint (PWS) or the maternal chromosome carries a paternal imprint (AS). Such an imprinting defect can result from an imprinting centre (IC) mutation or occur spontaneously. 6, 7, 8 Genotype-phenotype correlations in PWS and AS have revealed subtle clinical differences. 5 It appears as if microcephaly is less frequent in AS patients with an imprinting defect. 8 Furthermore, there are some case reports about AS patients with uniparental disomy and a milder phenotype. [9] [10] [11] [12] It should be noted, however, that genotype-phenotype studies can suffer from an ascertainment bias, because in general the patients are diagnosed according to standard diagnostic criteria. 2, 3 Thus, patients with atypical or very mild phenotypes may usually not be included in such studies and most often are identified by chance only. Here we report on a series of seven AS patients, who presented with some features of PWS. Interestingly, all of these patients have an imprinting defect. Our findings extend the previously known phenotypic spectrum of AS and may help to recognise more such patients.
Subjects and Methods

Ascertainment
Between 1993 and 1998 our diagnostic laboratory received blood samples from six patients who were suspected of having PWS, but turned out to have an AS methylation pattern. Two of these patients were then examined personally by one of the authors (GG-K). In another case, the mother suspected her daughter of having PWS and presented the child to this author.
Case Reports
Clinical pictures of patients 1-3, 5 and 7 are depicted in Figure 1 and Figure 2 .
Patient 1 (LM12690) Patient 1 was born as the second son to healthy parents. His birth weight was 4050 g ( + 1SD), length 54 cm (mean) and OFC 36.5 ( + 1SD). In spite of muscular hypotonia, his motor development was normal as he started walking independently at 16 months. A striking appetite was noted from the first months of life. At the age of 3 years his height was of 93 cm (-1.5SD) and he weighed 18 kg ( + 3SD). At age 7 years 5 months his height is 124 cm (-0.5SD) and his weight 32 kg ( + 2.5SD). He has a happy disposition and speaks a few words; his comprehension is very good. He has neither ataxia nor epilepsy. PWS was diagnosed clinically when he was 3 years old. This patient's data were partly described by Bürger et al. Patient 3 (HS311289) Patient 3 was delivered by Caesarean section as the second child to non-consanguineous parents. Birth weight was 3800 g (mean) and length 50 cm (-1.5SD). His older sister had a ventricular septal defect. From his first year of life developmental delay and muscular hypotonia have been obvious. He walked unsupported at 2 1 2 years of age. Speech development is severely impaired. At his present age of 8 years he is able to speak only two or three words. He developed seizures at the age of 12 months requiring antiepileptic therapy. Obesity has been present from early on. His height corresponds to the 25th percentile for age, OFC to P25, and his weight is above the 97th percentile. He presents with muscular hypotonia, micropenis and behaviour problems. Ataxia is not present. Facial features include almond-shaped eyes, downturned corners of the mouth and hypoplastic alae nasi. A clinical geneticist tentatively classified his clinical features as PWS.
Patient 4 (DS25393)
This girl was born after 36 weeks of gestation with a birth weight of 3220 g ( + 1SD), a length of 53 cm ( + 1.5SD) and a head circumference of 35 cm ( + 1.5SD). The parents were healthy and non-consanguineous. She presented with muscular hypotonia and her developmental milestones were delayed: at the age of 2 years she started to walk unaided and could say 'mama' and 'papa'. She has been overweight from her first months of life. During infancy she had a total of five febrile seizures. The awake EEG pattern shows a slight diminished activity. Rarely there are diffuse high-amplitude 1-3 Hz slow waves and spikes. She has no epilepsy. We examined her at the age of 5 years and 6 months. Her height is 114 cm (mean), weight is 28 kg ( + 4SD) and OFC 51 cm (mean) (Figure 1 ). She is able to speak about 20 words and comprehension is good. She shows behavioral problems, especially a tendency to be aggressive, and social contact with children of her age is poor. The neurological examination was normal and did not reveal ataxia. The diagnosis of PWS was tentatively made by her paediatrician because of the combination of obesity and speech delay.
Patient 5 (MX29790)
This girl was born after an uneventful pregnancy to healthy non-consanguineous German parents as their first daughter. Birth parameters were in the normal range: weight 3000 g (-1SD), length 54 cm ( + 1SD), OFC 34 (mean). She started walking at 18 months and spoke her first words at the age of 2 years. She now is 7 years 8 months old and is able to talk in two to four word sentences and answers appropriately to questions. Her speech, however, is hypernasal and difficult to understand. She enjoys eating and her weight is 30 kg ( + 1SD). Her height is 129 cm ( + 0.5SD) and OFC 50 cm (-1SD). She still presents with muscular hypotonia. During her first 6 years of life she had sleeping problems. The awake of EEG pattern shows high amplitude waves. Seizures have not been noticed. The mother knows a girl with PWS and therefore speculated that her daughter might have the same disorder. Being aware of the phenotype of the other patients, one of the authors (GG-K) suspected the girl to belong to a subgroup of patients with AS.
Patient 6 (MJ121095) This boy is the first child of healthy
German parents. At term he weighed 3750 g (mean), length was 54 cm (mean) and OFC was 36.5 cm ( + 1SD). Breast feeding was difficult and he had to be bottle fed. At the age of 8 months, the mother observed a developmental delay for which he was examined neuropaediatrically. Muscular hypotonia was documented. The EEG revealed delta waves of high amplitude. At our examination at the age of 23 months, he was able to sit unsupported but could not walk unaided. He had no active speech but comprehension was normal for age. His weight was 16 kg ( + 1.5SD) and height 95 cm ( + 2SD). He was macrocephalic with an OFC of 54 cm ( + 3.5SD). The neuropaediatricians suspected he had PWS because of the above mentioned features. At a re-examination at the age of 3.5 years, the patient showed massive obesity (25 kg; + 5SD). His height was 100 cm (mean). He is able to understand and has started to speak a few words.
Patient 7 (MA311090)
This patient is the only child of a young German couple. He was born after 35 weeks of gestation with a birth weight of 2640 g (mean) and a length of 49 cm ( + 0.5SD). He was reported to have neonatal muscular hypotonia and feeding problems. Obesity was obvious at the age of 4 years. At the age of 7 years and 10 months he had a length of 120 cm (-1SD) and a weight of 31 kg ( + 4SD). His OFC was 51 cm (-1SD). he is severely retarded with absence of speech, but displays neither ataxia nor epilepsy. Features such as muscular hypotonia, mental retardation and obesity suggested the clinical diagnosis of PWS. Molecular data (patient ASID-16) have been described before by Buiting et al. 
Cytogenetic Analysis and FISH
Routine cytogenetic analysis including GTG-banding of cultured blood lymphocytes was performed in all patients and their parents according to standard methods. 13 Fluorescence in situ hybridisation (FISH) was performed in each case (number of metaphases analysed: 50) as described by Lichter et al 14 using probes specific for the SNRPN and GABRB3 loci, which map to 15q11-q13, and a control probe for the PML locus, which maps to 15q22 (ONCOR). The hybridisation and immunochemical detection was carried out according to the manufacturer's recommendations.
DNA Analysis
DNA was extracted from peripheral blood by standard procedures. The methylation status was analysed by Southern blot analysis with PW71B (D15S63) 15 and by methylationspecific PCR for SNRPN. 16 To search for microdeletions in the IC, Southern blot hybridisations with probe IC1/3 were performed, which spans the shortest region of deletion overlap in AS patients with an IC deletion. 17 Microsatellites were studied with fluorescence-labelled primers and standard procedures. 6 
Results
Between 1993 and 1998 we identified seven patients who were suspected of having PWS, but turned out to have an AS methylation pattern. The patients presented with obesity, muscular hypotonia and mental retardation, but lacked ataxia, microcephaly and facial features typical of AS. Three patients had active speech and were able to communicate with others. The main clinical features are summarised in Table 1 .
Southern blot analysis with PW71B (D15S63) revealed a normal paternal band, but a faint maternal band (Figure 3) . Similar results were obtained by the methylation-specific PCR test for SNRPN: two patients (6 and 7) lacked the maternal band, two patients (1 and 3) had a very weak maternal band, and three patients (2, 4 and 5) had a weak maternal band (Figure 3) .
Cytogenetic analysis at the 400 band stage revealed normal chromosomes in the patients and their parents. FISH analysis with probes for SNRPN and GABRB3 gave signals in 15q11-q13 on both chromosomes (not shown). Thus there was no evidence of a deletion in this region. Microsatellite analysis of the patients and their parents showed biparental inheritance of at least two chromosome 15 loci in each case (Table 2 ). This result, in combination with the methylation patterns, suggests that the patients have a paternal imprint on the maternal chromosome, ie an imprinting defect. Southern blot analysis with a probe from the imprinting centre region did not reveal any deletion in this region (not shown).
Discussion
Absence of speech, early onset of seizures, mental retardation, ataxia and postnatal microcephaly represent the major features of Angelman syndrome. [1] [2] [3] Furthermore, the average birth weight in AS patients is 200 g less than in normal sibs. 2 Here we report on seven patients who have AS by molecular analysis, but lack most of the typical clinical features. Previous observations focused on a milder phenotype in AS patients with UPD. [9] [10] [11] [12] These patients showed a milder degree of ataxia and mental retardation, normal stature and head circumference as well as obesity. Minassian et al 18 reported that AS patients with a typical interstitial deletion of 15q11-q13 have more severe epilepsy than patients with UPD, a UBE3A mutation or an imprinting defect. Only one of our patients developed seizures. Atypical Angelman syndrome G Gillessen-Kaesbach et al t An abnormal EEG pattern was present in 5/7 patients, but this was not consistent with the changes typically seen in AS. In a study describing the phenotypical differences in AS patients of different molecular classes, Bürger et al 8 pointed out that microcephaly and hypopigmentation are less frequently observed in patients with imprinting mutations than in patients with deletions. Similar findings have been reported by Moncla et al. 5 Our study confirms these aspects. 5, 8, 18 All patients described by us had a normal head circumference for their age and normal pigmentation. In addition, they had normal or larger birth sizes, and all but one lacked epilepsy.
In contrast to previous genotype-phenotype studies in AS, however, our patients were not ascertained on the basis of clinical features suggestive of AS, but because of early onset of obesity, muscular hypotonia and mental retardation. These features do not belong to the 'classic' spectrum of features in AS, but could be suggestive of PWS. Since methylation analysis detects PWS and AS in the same test, a molecular diagnosis of AS was made, although initially PWS was suspected in the patients. Interestingly, patients 1-5 had a weak maternal band in the SNRPN test (Figure 3 ). Patients 6 and 7 had a typical methylation pattern and are more retarded than the other five patients. On the other hand, in a recent genotype-phenotype study, Moncla et al 5 described non-deleted AS patients who had a behavioural phenotype similar to PWS consisting of hyperphagia and an increase in weight. The phenotypic overlap of patients in this and our study may suggest that the atypical phenotype here represents the very end of a continuous phenotypic spectrum of AS patients.
Notably, all the patients described here have an imprinting defect. This classification is based on the finding of an abnormal methylation pattern in the presence of normal chromosomes of biparental origin. 7, 19 All cases are sporadic, and we have not found any evidence for an imprinting centre microdeletion. The mild phenotype may be due to an incomplete imprinting defect or to cellular mosaicism. As we cannot test the methylation and expression pattern of the AS gene(s) in brain, it is possible that the imprinting defect does not extend from the imprinting centre to these genes in each cell. Alternatively, some of the patients, especially those presenting with a weak maternal SNRPN band, may be somatic mosaics in which cells with a normal imprint and cells with an imprinting defect coexist. Mosaicism may result from a postzygotic error of imprint maintenance or from the postzygotic correction of an imprint incorrectly set in the parental germline. At present, it is not possible to distinguish between these possibilities. Attempts to explain the phenotype in the patients described here are hampered by incomplete knowledge about the genes involved in AS and PWS. At present it is not clear whether UBE3A is the only AS gene, or whether the GABRB3 gene or other genes contribute to the phenotype, at least in patients with a deletion. 20 Furthermore, the imprinting status of GABRB3 is a matter of debate. 21 Last, but not least, the etiology of obesity in PWS is still unknown. In PWS obesity usually starts in early childhood, whereas our patients with AS were already overweight in their first year of life. This observation suggests that different genes might play a role in the etiology of obesity in the two conditions. On the other hand, the presence of muscular hypotonia in both groups of patients may point to the involvement of the same gene(s). Nevertheless, it is difficult to explain the presence of these features in patients with PWS, who lack a paternal contribution in 15q11-q13, and in AS patients with an imprinting defect and uniparental disomy, who have a double dosage of paternally expressed genes.
In view of the fact that major features of AS are absent in the seven patients reported here, it raises the question whether these patients should be classified as AS solely on the basis of their methylation pattern. From a molecular point of view, the answer is yes, and the patients extend the currently known phenotypic spectrum of AS. From a clinical point of view, however, the answer is less clear. These patients lack several of the most characteristic features of AS. However, we think, that AS patients of different molecular classes share important features like mental retardation and speech problems. Therefore, such children may benefit from joining an AS support group.
In conclusion, we have identified a group of patients with a chromosome 15 imprinting defect who have atypical AS. The absence of speech was hitherto regarded as an almost mandatory feature of AS. Following current diagnostic criteria, an experienced clinician would not have made the diagnosis of AS or PWS in these patients. Our accidental finding of these patients reinforces the idea of performing a methylation test in all children presenting with obesity, muscular hypotonia and mental retardation. Knowing the phenotype of the patients described here may also help to recognise this form of AS more often.
